"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry.
Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible
insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.
In this interview, News Medical speaks with Ascential Technologies about the evolution of medical manufacturing trends and how users can stay ahead of the trends moving forward.
In this interview, Michael Nilsson, the Assistant Director of Liquid Handling at FORMULATRIX , talks to News Medical about simplifying assay development and optimization and the different instruments that can be used to minimize cost.
In this new omg OMx podcast episode, Bruker's Kate Stumpo speaks to Nicola Ternette on the incredible world of immunopeptidomics - the implications they could have for research and how they help us
understand the immune system better.
An interview with Dr. Rajas Warke, Director of Molecular Biology and virology at HiMedia Labs.
In this interview with NewsMedical, Dr. Yousef Nazirizadeh offers insights into the advanced functionalities and diverse types of Byonoy's plate readers, underscoring their significance in the industry.
In this interview, News Medical talks to DeNovix about the best way to prepare nuclei samples before single cell sequencing workflows and optimize nuclei extraction.
In the latest episode of the OMG Omx podcast, Bruker's Kate Stumpo talks to Nikolai Slavov about the incredible potential of mass spectrometry proteomics in biomedical research.
In this interview, Rob Trainor, the Vice President of Operations at Sphere Fluidics, sits down for an insightful conversation detailing the completion of Sphere Fluidics' new state-of-the-art facilities and the strategic decisions behind their office move and rebranding.
In this interview, Grace Liu from Sino Biological discusses the crucial role of biomarkers in cancer prevention and diagnosis and how they can help guide treatment decisions.
In this interview, News Medical speaks to Donovan Quill, Executive Vice President of Growth &
Strategy at AscellaHealth about the recurring challenges met when seeking market access for rare disease
In this interview, NewsMedical talks to James Brady about cell-based therapy and how the field of genetic engineering transformed.
We spoke to Professor Janet Hemingway, founding Director of iiCON and Professor of Tropical Medicine at Liverpool School of Tropical Medicine.
In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Ulrike Kuenzel, Associate Director in the Functional Genomics department at AstraZeneca about the application of arrayed CRISPR screening for target identification and more.
In this interview, News Med talks to Lisa Cratty about the unpredictable lab environment and
The baculovirus–insect cell expression system—insect cells used in conjunction with the baculovirus
expression vector system (BEVS)— remains a crucial technology for manufacturing large and complex
proteins. This eukaryotic expression system offers inherent safety, ease of scale-up, flexible product
design, and versatility for a broad range of proteins.
In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Silvio Di Castro about his research, as well as the role of compound management in pharmaceutical research.
In this new podcast, Bruker's Kate Stumpo talks with Enveda's Pelle Simpson on the opportunities of natural products in the field of multiomics.
In this interview, NewsMedical speaks with Jeff Hawkins, CEO of Quantum-Si, about the challenges of conventional proteomic methods, as well as how next-generation protein sequencing is democratizing protein sequencing.
In this interview, AZoNetwork speaks with Joe Barco, the Senior Director of Workflow Marketing at Unchained Labs, about the benefits of automated buffer exchange with Big Tuna.
In this interview, News-Medical had the opportunity to speak with Dr. Xiaobing Han, Principal Scientist for Antibody Discovery at Rapid Novor.